The State Administration of pharmaceutical supervision will focus on the market of medicinal materials in hand

The State Food and Drug Administration today announced the launch of the "two strikes and two constructions" of drugs, and made it a top priority to crack down on and rectify problems in the field of traditional Chinese medicine Yan Jiangying, a spokesman for the State Food and drug administration, said the special event will work with the Ministry of Commerce to rectify and build a specialized market for traditional Chinese medicine and establish a mechanism for drug risk prevention and control Li Guoqing, director of the Department of drug safety supervision, said that the current problems in the field of traditional Chinese medicine, including the cultivation of traditional Chinese medicine, the use of fake and inferior traditional Chinese medicine in rough processing, and unauthorized production of traditional Chinese medicine extracts, were also the focus of the crackdown According to the plan, "two strikes and two constructions" will crack down on the illegal production of traditional Chinese medicine and regulate the specialized market of traditional Chinese medicine The production of traditional Chinese medicine will focus on cracking down on pieces of traditional Chinese medicine, including weight-added dyeing and adulteration in the production of pieces of traditional Chinese medicine; the professional market of traditional Chinese medicine will prohibit the sale of pieces of traditional Chinese medicine, proprietary Chinese medicine or chemicals If there are serious problems in the specialized market of traditional Chinese medicine and the rectification is not effective, it shall be resolutely closed down The activities of "two strikes and two constructions", that is to say, the State Food and drug administration has carried out nationwide activities to crack down on the illegal production of drugs, crack down on the illegal operation of drugs, strengthen the construction of the norms of drug production and operation and strengthen the construction of the drug supervision mechanism, and will focus on the supervision of the current prominent problems for half a year.